Thrombosis |
From the Wihuri Research Institute, Helsinki, Finland (P.K., P.T.K., R.L.), and Helsinki University Central Hospital, Department Internal Medicine (R.L.).
Correspondence to Dr Riitta Lassila, Wihuri Research Institute, Kalliolinnantie 4, FIN-00140, Helsinki, Finland. E-mail riitta.lassila{at}wri.fimnet.fi
AbstractWe coimmobilized mast cellderived heparin proteoglycans (HEP-PGs) of very high molecular weight (750 kDa) or unfractionated heparin (UFH) on coverslips together with collagen without altering the amount of immobilized collagen. Subsequently, platelet-collagen interactions were studied under both flowing and static conditions in D-phenylalanyl-L-prolyl-L-arginine chloromethyl ketoneanticoagulated blood and platelet-rich plasma (PRP), respectively. At a high shear rate (1600 1/s), the mean platelet deposition (PD) on collagen monomers was 7.5±6.1x106/cm2 (n=5). When the monomers were coimmobilized with UFH, PD was inhibited by 73% (2.0±1.2x106/cm2), whereas HEP-PG completely blocked it (0.42±0.38x106/cm2; P<0.05). Also, when collagen fibrils were used for coating, HEP-PG significantly inhibited PD. At a low shear rate (200 1/s) and under static conditions in PRP, the inhibitory effect of HEP-PG on PD was less marked. Inhibition of glycoprotein IIb/IIIa did not affect PD on coimmobilized HEP-PG in contrast to coimmobilized UFH or collagen alone. As a sign of inactivation, platelets adhering to the HEP-PG surface released considerably less ß-thromboglobulin than did those adhering to pure collagen. In summary, immobilized HEP-PG strongly inhibited PD on collagen by attenuating adhesion-induced platelet activation. The stronger effect on collagen monomers suggests the inhibition of glycoprotein Ia/IIamediated activation.
Key Words: collagen heparin proteoglycans mast cells platelets
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |